Your session is about to expire
← Back to Search
Ketamine for Tinnitus
Study Summary
This trial is testing if ketamine, an antagonist at the NMDA receptor, can help treat tinnitus by increasing GABA levels in the brain. So far, it only works for tinnitus that results from acute injury, not from progressive hearing loss.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had ringing in my ears and some hearing loss for at least 6 months.My tinnitus is caused by hearing loss, not another disease.I have moderate to severe depression and some anxiety.I am between 21 and 60 years old.I have had ringing in my ears and some hearing loss for at least 6 months.I am between 21 and 60 years old.You have a high score on a tinnitus questionnaire and a certain level of difficulty hearing sounds.I have a history of serious health issues like high blood pressure or heart disease.You have metal implants or objects in your body that cannot be removed for scans.I have moderate to severe depression and some anxiety.My tinnitus is severe enough to affect my daily life and can be masked by sounds over 5dB.I have had ringing in my ears and some hearing loss for over 6 months.My tinnitus is caused by hearing loss, not another disease.I have moderate to severe depression and some anxiety.My tinnitus is caused by hearing loss, not another medical condition.My tinnitus is caused by hearing loss, not another disease.You have severe psychiatric disorders other than mild to moderate depression and anxiety, and substance use disorder.I have used ketamine recreationally, as an anesthetic, or had a bad reaction to it.I am currently on medication for mental health issues.I am between 21 and 60 years old.My tinnitus is severe enough to affect my daily life and hearing tests confirm it.
- Group 1: Tinnitus Distressed Patients
- Group 2: Tinnitus Patients
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experiment seek out participants in the senior age range?
"Consistent with its inclusion criteria, the lower limit for enrollment in this trial is 21 and no patient may be older than 60."
Is the use of Ketamine Hydrochloride diluted in saline sanctioned by the FDA?
"Our in-house team at Power assessed the safety of Ketamine Hydrochloride in saline as a 2, since this is currently a Phase 2 clinical trial with some evidence to suggest it's safe but none to indicate its efficacy."
Are medical professionals currently recruiting participants for this trial?
"Affirmative. Clinicaltrials.gov's records indicate that the trial, first posted on September 1st 2019, is currently accepting patients and plans to recruit 40 individuals from 2 sites."
Is my eligibility sufficient to partake in the experiment?
"This clinical trial, which is open to those between 21 and 60 years of age suffering from tinnitus, seeks 40 participants. To qualify for the study they must have a score of 14 or more on the Hamilton Depression Rating Scale with an anxiety rating of at least 2 (in the distressed group), a Tinnitus Handicap Inventory rating greater than 32, masked hearing loss above 5dB as well as sensori-neural hearing impairment lasting 6 months or longer that isn't related to medical disease."
How many participants are eligible to join this clinical experiment?
"Affirmative. On clinicaltrials.gov, the information confirms that this trial which was initially posted on September 1st 2019 is now actively recruiting patients. Approximately 40 participants are being sought from 2 different medical sites."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger